- Home
- SAN vs ABT Comparison
SAN vs ABT Comparison
Compare SAN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SAN | ABT |
|---|---|---|
| Founded | 1857 | 1888 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.6B | 173.2B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SAN | ABT |
|---|---|---|
| Price | $13.58 | $102.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 28 |
| Target Price | $14.79 | ★ $120.72 |
| AVG Volume (30 Days) | ★ 7.7M | 5.4M |
| Earning Date | 10-28-2026 | 10-21-2026 |
| Dividend Yield | 1.55% | ★ 2.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $2.29 | $13.25 |
| Revenue Next Year | $8.55 | $8.62 |
| P/E Ratio | ★ $11.21 | $163.21 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $9.62 | $81.97 |
| 52 Week High | $15.05 | $133.34 |
Technical Indicators
Market Signals| Indicator | SAN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 50.29 |
| Support Level | $13.24 | $100.60 |
| Resistance Level | $13.78 | $104.19 |
| Average True Range (ATR) | 0.24 | 2.05 |
| MACD | -0.08 | 0.29 |
| Stochastic Oscillator | 26.30 | 69.50 |
Price Performance
Historical ComparisonAbout SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander runs five global businesses: retail and commercial banking, corporate and investment banking, wealth management and insurance, payments, and a digital platform Openbank. Spain is the largest single profit contributor, followed by Brazil, the United States, Mexico and the United Kingdom.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.